LWAY

LWAY
Income Statement
| Period | Revenue | Operating Expense | Net Income | Net Profit Margin | Earnings Per Share | EBITDA |
|---|---|---|---|---|---|---|
| Q3-2025 | $57.143M ▲ | $12.282M ▲ | $3.529M ▼ | 6.176% ▼ | $0.23 ▼ | $6.162M ▼ |
| Q2-2025 | $53.901M ▲ | $9.605M ▲ | $4.249M ▲ | 7.883% ▲ | $0.28 ▲ | $6.899M ▲ |
| Q1-2025 | $46.091M ▼ | $9.461M ▼ | $3.54M ▲ | 7.68% ▲ | $0.24 ▲ | $5.917M ▲ |
| Q4-2024 | $46.934M ▲ | $11.184M ▲ | $-160K ▼ | -0.341% ▼ | $-0.011 ▼ | $1.678M ▼ |
| Q3-2024 | $46.095M | $7.678M | $2.976M | 6.456% | $0.2 | $5.185M |
Balance Statement
| Period | Cash & Short-term | Total Assets | Total Liabilities | Total Equity |
|---|---|---|---|---|
| Q3-2025 | $22.99M ▲ | $109.526M ▲ | $26.762M ▲ | $82.764M ▲ |
| Q2-2025 | $21.22M ▲ | $98.267M ▲ | $19.571M ▲ | $78.696M ▲ |
| Q1-2025 | $19.446M ▲ | $93.667M ▲ | $19.499M ▲ | $74.168M ▲ |
| Q4-2024 | $16.728M ▼ | $90.547M ▼ | $18.636M ▼ | $71.911M ▲ |
| Q3-2024 | $20.558M | $91.309M | $19.786M | $71.523M |
Cash Flow Statement
| Period | Net Income | Cash From Operations | Cash From Investing | Cash From Financing | Net Change | Free Cash Flow |
|---|---|---|---|---|---|---|
| Q3-2025 | $3.529M ▼ | $6.919M ▲ | $-5.149M ▼ | $0 | $1.77M ▼ | $1.77M ▲ |
| Q2-2025 | $4.249M ▲ | $3.912M ▲ | $-2.138M ▼ | $0 ▲ | $1.774M ▼ | $1.605M ▲ |
| Q1-2025 | $3.54M ▲ | $-150K ▲ | $2.933M ▲ | $-65K ▼ | $2.718M ▲ | $-2.369M ▲ |
| Q4-2024 | $-160K ▼ | $-2.579M ▼ | $-1.251M ▲ | $0 | $-3.83M ▼ | $-3.831M ▼ |
| Q3-2024 | $2.976M | $7.451M | $-1.526M | $0 | $5.925M | $5.911M |
Five-Year Company Overview
Income Statement

Balance Sheet

Cash Flow

Competitive Edge

Innovation and R&D

Summary
Lifeway Foods has evolved from a niche kefir producer into a profitable, category-leading probiotic foods company with a measurable competitive moat. The income statement now reflects steady growth and consistent, if still modest, profitability. The balance sheet is conservative, with little to no debt and gradually rising equity, and cash flows have improved to the point where the business can fund expansion from internal resources. Strategically, its strongest advantages are brand strength, proprietary fermentation know-how, and broad distribution in major retailers. Key opportunities lie in extending its probiotic expertise into new products and formats, while main risks include reliance on a relatively narrow product category, changing consumer tastes in dairy, and execution challenges as it scales its “Lifeway 2.0” growth plan. Overall, it is a focused, innovation-driven player in the functional foods space with improving financial resilience.
NEWS
November 26, 2025 · 10:00 AM UTC
Edward Smolyansky Files Preliminary Proxy Statement toward Achieving Further Board Change and a New Beginning for Lifeway Foods, Inc. (NASDAQ: LWAY)
Read more
November 21, 2025 · 3:05 PM UTC
Kefir-Leader Lifeway Foods Expands Farmer Cheese Distribution to 2,000 Walmart Stores Across the U.S.
Read more
November 12, 2025 · 9:00 AM UTC
Lifeway Foods Delivers Record Q3 2025 Net Sales and Strong Net Income Growth Continuing Kefir Category Dominance
Read more
November 11, 2025 · 9:00 AM UTC
Lifeway Foods and Drugstore Launch Limited-Edition Smoothie for November: Lifeway Probiotic Sunrise Smoothie
Read more
November 10, 2025 · 10:05 AM UTC
Lifeway Foods to Host Ribbon Cutting for Phase Two of $45 Million Waukesha Expansion, Advancing Cooling System Upgrades to Support Global Kefir Demand
Read more
About Lifeway Foods, Inc.
https://lifewaykefir.comLifeway Foods, Inc. produces and markets probiotic-based products in the United States and internationally. Its primary product is drinkable kefir, a cultured dairy product in various organic and non-organic sizes, flavors, and types, including low fat, non-fat, whole milk, protein, and BioKefir.
Income Statement
| Period | Revenue | Operating Expense | Net Income | Net Profit Margin | Earnings Per Share | EBITDA |
|---|---|---|---|---|---|---|
| Q3-2025 | $57.143M ▲ | $12.282M ▲ | $3.529M ▼ | 6.176% ▼ | $0.23 ▼ | $6.162M ▼ |
| Q2-2025 | $53.901M ▲ | $9.605M ▲ | $4.249M ▲ | 7.883% ▲ | $0.28 ▲ | $6.899M ▲ |
| Q1-2025 | $46.091M ▼ | $9.461M ▼ | $3.54M ▲ | 7.68% ▲ | $0.24 ▲ | $5.917M ▲ |
| Q4-2024 | $46.934M ▲ | $11.184M ▲ | $-160K ▼ | -0.341% ▼ | $-0.011 ▼ | $1.678M ▼ |
| Q3-2024 | $46.095M | $7.678M | $2.976M | 6.456% | $0.2 | $5.185M |
Balance Statement
| Period | Cash & Short-term | Total Assets | Total Liabilities | Total Equity |
|---|---|---|---|---|
| Q3-2025 | $22.99M ▲ | $109.526M ▲ | $26.762M ▲ | $82.764M ▲ |
| Q2-2025 | $21.22M ▲ | $98.267M ▲ | $19.571M ▲ | $78.696M ▲ |
| Q1-2025 | $19.446M ▲ | $93.667M ▲ | $19.499M ▲ | $74.168M ▲ |
| Q4-2024 | $16.728M ▼ | $90.547M ▼ | $18.636M ▼ | $71.911M ▲ |
| Q3-2024 | $20.558M | $91.309M | $19.786M | $71.523M |
Cash Flow Statement
| Period | Net Income | Cash From Operations | Cash From Investing | Cash From Financing | Net Change | Free Cash Flow |
|---|---|---|---|---|---|---|
| Q3-2025 | $3.529M ▼ | $6.919M ▲ | $-5.149M ▼ | $0 | $1.77M ▼ | $1.77M ▲ |
| Q2-2025 | $4.249M ▲ | $3.912M ▲ | $-2.138M ▼ | $0 ▲ | $1.774M ▼ | $1.605M ▲ |
| Q1-2025 | $3.54M ▲ | $-150K ▲ | $2.933M ▲ | $-65K ▼ | $2.718M ▲ | $-2.369M ▲ |
| Q4-2024 | $-160K ▼ | $-2.579M ▼ | $-1.251M ▲ | $0 | $-3.83M ▼ | $-3.831M ▼ |
| Q3-2024 | $2.976M | $7.451M | $-1.526M | $0 | $5.925M | $5.911M |
Five-Year Company Overview
Income Statement

Balance Sheet

Cash Flow

Competitive Edge

Innovation and R&D

Summary
Lifeway Foods has evolved from a niche kefir producer into a profitable, category-leading probiotic foods company with a measurable competitive moat. The income statement now reflects steady growth and consistent, if still modest, profitability. The balance sheet is conservative, with little to no debt and gradually rising equity, and cash flows have improved to the point where the business can fund expansion from internal resources. Strategically, its strongest advantages are brand strength, proprietary fermentation know-how, and broad distribution in major retailers. Key opportunities lie in extending its probiotic expertise into new products and formats, while main risks include reliance on a relatively narrow product category, changing consumer tastes in dairy, and execution challenges as it scales its “Lifeway 2.0” growth plan. Overall, it is a focused, innovation-driven player in the functional foods space with improving financial resilience.
NEWS
November 26, 2025 · 10:00 AM UTC
Edward Smolyansky Files Preliminary Proxy Statement toward Achieving Further Board Change and a New Beginning for Lifeway Foods, Inc. (NASDAQ: LWAY)
Read more
November 21, 2025 · 3:05 PM UTC
Kefir-Leader Lifeway Foods Expands Farmer Cheese Distribution to 2,000 Walmart Stores Across the U.S.
Read more
November 12, 2025 · 9:00 AM UTC
Lifeway Foods Delivers Record Q3 2025 Net Sales and Strong Net Income Growth Continuing Kefir Category Dominance
Read more
November 11, 2025 · 9:00 AM UTC
Lifeway Foods and Drugstore Launch Limited-Edition Smoothie for November: Lifeway Probiotic Sunrise Smoothie
Read more
November 10, 2025 · 10:05 AM UTC
Lifeway Foods to Host Ribbon Cutting for Phase Two of $45 Million Waukesha Expansion, Advancing Cooling System Upgrades to Support Global Kefir Demand
Read more

CEO
Julie Smolyansky
Compensation Summary
(Year 2023)

CEO
Julie Smolyansky
Compensation Summary
(Year 2023)
Split Record
| Date | Type | Ratio |
|---|---|---|
| 2006-08-16 | Forward | 2:1 |
| 2004-03-09 | Forward | 2:1 |
Ratings Snapshot
Rating : A-
Most Recent Analyst Grades
Grade Summary
Institutional Ownership

DIVISADERO STREET CAPITAL MANAGEMENT, LP
630.183K Shares
$15.619M

RENAISSANCE TECHNOLOGIES LLC
417.771K Shares
$10.354M

VANGUARD GROUP INC
311.937K Shares
$7.731M

BLACKROCK, INC.
282.45K Shares
$7.001M

BLACKROCK INC.
248.017K Shares
$6.147M

DIMENSIONAL FUND ADVISORS LP
245.478K Shares
$6.084M

BLACKROCK FUND ADVISORS
152.171K Shares
$3.772M

GAMCO INVESTORS, INC. ET AL
151.35K Shares
$3.751M

SLOTNIK CAPITAL, LLC
141.761K Shares
$3.514M

FINANCIAL & INVESTMENT MANAGEMENT GROUP LTD
133.979K Shares
$3.321M

GEODE CAPITAL MANAGEMENT, LLC
130.516K Shares
$3.235M

TWO SIGMA INVESTMENTS, LP
101.311K Shares
$2.511M

TUDOR INVESTMENT CORP ET AL
94.405K Shares
$2.34M

STATE STREET CORP
85.457K Shares
$2.118M

TIG ADVISORS, LLC
76.059K Shares
$1.885M

GABELLI FUNDS LLC
69.817K Shares
$1.73M

GABELLI & CO INVESTMENT ADVISERS, INC.
62.746K Shares
$1.555M

BANK OF NEW YORK MELLON CORP
58.957K Shares
$1.461M

NORTHERN TRUST CORP
56.227K Shares
$1.394M

DE LISLE PARTNERS LLP
53.782K Shares
$1.333M
Summary
Only Showing The Top 20


